Role_NN
for_IN
the_DT
Epstein-Barr_JJ
virus_NN
nuclear_JJ
antigen_NN
2_CD
in_IN
viral_JJ
promoter_NN
switching_NN
during_IN
initial_JJ
stages_NNS
of_IN
infection_NN
._.

During_IN
latent_JJ
Epstein-Barr_JJ
virus_NN
-LRB-_-LRB-
EBV_NN
-RRB-_-RRB-
infection_NN
of_IN
human_JJ
B_NN
lymphocytes_NNS
,_,
six_CD
viral_JJ
nuclear_JJ
antigen_NN
-LRB-_-LRB-
EBNAs_NN
-RRB-_-RRB-
are_VBP
expressed_VBN
from_IN
long_JJ
primary_JJ
transcripts_NNS
by_IN
means_NNS
of_IN
alternative_JJ
splicing_NN
and_CC
alternative_JJ
polyadenylylation_NN
sites_NNS
._.

These_DT
transcripts_NNS
initiate_VBP
from_IN
one_CD
of_IN
two_CD
promoters_NNS
,_,
Cp_NN
or_CC
Wp_NN
,_,
that_WDT
function_VBP
in_IN
a_DT
mutually_RB
exclusive_JJ
fashion_NN
._.

Wp_NN
is_VBZ
exclusively_RB
utilized_VBN
during_IN
the_DT
initial_JJ
stages_NNS
of_IN
infection_NN
of_IN
primary_JJ
B_NN
lymphocytes_NNS
,_,
followed_VBN
by_IN
a_DT
switch_NN
to_TO
Cp_NN
usage_NN
._.

These_DT
studies_NNS
have_VBP
been_VBN
extended_VBN
to_TO
show_VB
that_IN
-LRB-_-LRB-
i_LS
-RRB-_-RRB-
a_DT
mutant_JJ
EBV_NN
strain_NN
lacking_VBG
the_DT
gene_NN
encoding_VBG
EBNA_NN
2_CD
fails_VBZ
to_TO
switch_VB
from_IN
Wp_NN
to_TO
Cp_NN
usage_NN
in_IN
primary_JJ
B_NN
lymphocytes_NNS
,_,
although_IN
the_DT
virus_NN
contains_VBZ
a_DT
functional_JJ
Cp_NN
;_:
-LRB-_-LRB-
ii_LS
-RRB-_-RRB-
a_DT
region_NN
from_IN
-429_CD
to_TO
-245_CD
base_NN
pairs_NNS
upstream_JJ
of_IN
Cp_NN
is_VBZ
essential_JJ
for_IN
Cp_NN
activity_NN
in_IN
B_NN
lymphocytes_NNS
,_,
but_CC
only_RB
in_IN
the_DT
context_NN
of_IN
upstream_JJ
and_CC
downstream_JJ
sequences_NNS
;_:
-LRB-_-LRB-
iii_LS
-RRB-_-RRB-
this_DT
region_NN
contains_VBZ
an_DT
EBNA_NN
2-dependent_JJ
enhancer_NN
;_:
and_CC
-LRB-_-LRB-
iv_LS
-RRB-_-RRB-
DNase_NN
I_NN
protection_NN
employing_VBG
nuclear_JJ
extracts_NNS
from_IN
B_NN
and_CC
T_NN
lymphocytes_NNS
revealed_VBD
a_DT
B-cell-specific_JJ
footprint_NN
in_IN
the_DT
region_NN
of_IN
the_DT
EBNA_NN
2-dependent_JJ
enhancer_NN
._.

These_DT
results_NNS
support_VBP
a_DT
model_NN
for_IN
viral_JJ
promoter_NN
switching_NN
during_IN
the_DT
initial_JJ
stages_NNS
of_IN
infection_NN
in_IN
which_WDT
Wp_NN
activity_NN
leads_VBZ
to_TO
the_DT
expression_NN
of_IN
EBNA_NN
2_CD
,_,
followed_VBN
by_IN
activation_NN
of_IN
Cp_NN
through_IN
the_DT
EBNA_NN
2-dependent_JJ
enhancer_NN
._.

